Category
News & Pipeline
Regulatory moves, new treatments and what's coming next in men's hormone care.
FTC Targets Online TRT Clinics: 2026 Cases
Hims faces an FTC health-data lawsuit; Keeps settled with the New York AG over subscriptions. What the 2026 actions mean for online TRT patients.
Read →
Keeps TRT Settlement 2026: NY AG Secures $400K
The Keeps TRT settlement of $400,000 with the NY AG ended a probe into hidden subscription fees, auto-renewal traps, and cancellation obstacles.
Read →
DEA Special Registration 2026: Final Review
DEA special registration 2026 rule entered OIRA review August 25. What the November decision means for online TRT patients and which clinics are safest.
Read →
FDA TRT Libido 2026: New Testosterone Indication for Men
FDA's proposed TRT libido indication: what changes for men with idiopathic hypogonadism, and which prescribing standards still apply.
Read →
Endocrine Society TRT 2026: The 12% Problem
TRT diagnostic standards: symptoms, repeat testosterone testing and what the Endocrine Society guidelines mean when choosing an online clinic.
Read →
Is Online TRT Legal? DEA Telehealth Rules, State Laws and the December 2026 Deadline
DEA telehealth TRT 2026 flexibilities expire December 31. Here's what the deadline means for men getting testosterone therapy online. And what to do now.
Read →
FDA Testosterone Label Change 2026: What It Means
The FDA testosterone label change of June 2026 removes the age-related low-T exclusion. Here is what this ruling means for men seeking TRT online in 2026.
Read →
FDA Drops Testosterone's Heart-Risk Warning (2026)
The FDA dropped the decade-old cardiovascular boxed warning from testosterone labels. What changed. And what it means if you're on or considering TRT.
Read →